Home Stakeholders Health Research Stakeholders Professor Amitava Banerjee – The Institute of Health Informatics

Professor Amitava Banerjee – The Institute of Health Informatics

Using health informatics to conduct high quality research that leverages big data, health and bioinformatics approaches to improve health

Amitava Banerjee is Professor of Clinical Data Science, University College London, and Consultant Cardiologist at University College London Hospitals and Barts Health NHS Trusts. He is a researcher, educator and clinician with interests spanning data science, cardiovascular disease, global health, training and evidence-based healthcare. In addition to general cardiology, he has special interest in heart failure and atrial fibrillation, and also the role of informatics and electronic health records in delivering better patient care. He has been active clinically and academically throughout the pandemic, and is the principal investigator of the STIMULATE-ICP study.

After qualifying from Oxford, he trained in Oxford, Newcastle, Hull and London, completing a Masters in Public Health at Harvard(2004/05), an internship at World Health Organisation(2005) and DPhil in epidemiology from Oxford(2010). He was Clinical Lecturer in Cardiovascular Medicine in Birmingham, before moving to UCL in 2015.

STIMULATE-ICP

A major new consortium of over 30 researchers, health professionals, patients and industry partners from over 30 organisations, led by University College London Hospitals NHS Trust and University College London, will conduct the largest clinical study of long COVID to-date over two years. As countries around the world struggle to cope and recover from successive waves of the pandemic, this NIHR-funded research programme will inform medium and longer-term policy and health system responses.

STIMULATE-ICP (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) will deliver knowledge to clinicians and scientists, evidence to policymakers, and improved care to patients, while collecting real-world data at scale. The team spans a wide range of relevant clinical and academic disciplines including primary care and specialist services, epidemiology, mental health and health economics.  It also includes four patient groups who helped develop the research proposals.

A trial, coordinated by the University of Central Lancashire, will recruit over 4,500 people with long-COVID, starting with six sites in Hull, Derby, Leicester, Liverpool, London and Exeter.  As well as evaluating current care, the study will include evaluation of community-based, comprehensive MRI scan (using CoverscanTM developed by Perspectum) and enhanced rehabilitation (Living with COVID RecoveryTM developed by Living With), to inform a new integrated care pathway for people with long COVID. Within this study, another trial will test different drugs, such as rivaroxaban and colchicine, to measure effects of three months treatment on symptoms, mental health, return to work and other important outcomes.

University College London

University College London (UCL) is London’s leading multidisciplinary university, with approximately 11,000 staff and 38,000 students from 150 different countries.  The university operates in a global context and is committed to excellence, innovation and the promotion of global understanding in all activities: research, teaching, learning, enterprise and community engagement.  UCL was the top-rated university for research strength in the Research Excellence Framework (REF), published in December 2014.

Institute Of Health Informatics (IHI)

The Institute of Health Informatics (IHI) was established in August 2014 as part of the Faculty of Population Health Sciences (FPHS) within the UCL School of Life and Medical Sciences (SLMS).  The Faculty of Population Health Sciences has established itself as UCL’s largest research-based faculty encompassing seven institutes. The Institute Director is Professor Harry Hemingway.

The aim of the IHI is to conduct high quality research that leverages big data and health and bioinformatics approaches to improve health at local, national and international levels. Our cutting edge programmes of research span the areas of Discovery Science, Precision Medicine, Learning Health Systems, Public Health and Citizen Driven Health. These programmes of research are underpinned by: excellent secure data infrastructure; adding value to key linked data resources to make data research-ready; development of multidisciplinary methodological expertise; engagement with patients, the public and health services; strong local, national and international academic partnerships and excellent multidisciplinary training programmes. The Institute leads major programmes of work in the NIHR UCLH/UCL Biomedical Research Centre, CALIBER, genomics England Electronic Health Records Clinical Interpretation Partnership (GeCIP), Big Data@Heart among others.

STIMULATE-ICP

A major new consortium of over 30 researchers, health professionals, patients and industry partners from over 30 organisations, led by University College London Hospitals NHS Trust and University College London, will conduct the largest clinical study of long COVID to-date over two years. As countries around the world struggle to cope and recover from successive waves of the pandemic, this NIHR-funded research programme will inform medium and longer-term policy and health system responses.

STIMULATE-ICP (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) will deliver knowledge to clinicians and scientists, evidence to policymakers, and improved care to patients, while collecting real-world data at scale. The team spans a wide range of relevant clinical and academic disciplines including primary care and specialist services, epidemiology, mental health and health economics.  It also includes four patient groups who helped develop the research proposals.

Stakeholder Profiles